第四大支柱：尽管在临床方面遭遇了一些挫折，但免疫疗法在成为癌症治疗的另一种选择方面取得了显著进展。
The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer.
机构信息
London, UK.
出版信息
EMBO Rep. 2017 Nov;18(11):1889-1892. doi: 10.15252/embr.201745172. Epub 2017 Oct 11.
Abstract
Immunotherapy based on anti‐cancer vaccines and checkpoint inhibitors of the immune system could become the fourth therapeutic approach to treat cancer. It still requires a better understanding of how and against which cancers it is most efficient. [Image: see text]
摘要
基于抗癌疫苗和免疫系统检查点抑制剂的免疫疗法可能成为治疗癌症的第四种治疗方法。它仍然需要更好地了解它是如何以及针对哪些癌症最有效的。[图片：见正文]
相似文献
1
The fourth pillar: Despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer.第四大支柱：尽管在临床方面遭遇了一些挫折，但免疫疗法在成为癌症治疗的另一种选择方面取得了显著进展。
EMBO Rep. 2017 Nov;18(11):1889-1892. doi: 10.15252/embr.201745172. Epub 2017 Oct 11.
2
Therapeutic cancer vaccines: From initial findings to prospects.治疗性癌症疫苗：从初步发现到展望。
Immunol Lett. 2018 Apr;196:11-21. doi: 10.1016/j.imlet.2018.01.011. Epub 2018 Feb 4.
3
Personalized neoantigen vaccines: A new approach to cancer immunotherapy.个体化新抗原疫苗：癌症免疫治疗的新途径。
Bioorg Med Chem. 2018 Jun 1;26(10):2842-2849. doi: 10.1016/j.bmc.2017.10.021. Epub 2017 Oct 19.
4
Cancer vaccines and immunotherapy.癌症疫苗与免疫疗法。
Hum Vaccin. 2009 Oct;5(10):666. doi: 10.4161/hv.5.10.9132. Epub 2009 Oct 1.
5
Cancer immunotherapy: moving beyond current vaccines.癌症免疫疗法：超越现有疫苗
Nat Med. 2004 Sep;10(9):909-15. doi: 10.1038/nm1100.
6
Personalized vaccines for cancer immunotherapy.用于癌症免疫治疗的个体化疫苗。
Science. 2018 Mar 23;359(6382):1355-1360. doi: 10.1126/science.aar7112.
7
Personalized tumor vaccines keep cancer in check.个性化肿瘤疫苗可控制癌症。
Science. 2017 Apr 14;356(6334):122. doi: 10.1126/science.356.6334.122.
8
Dendritic cell-based vaccines and therapies for cancer.基于树突状细胞的癌症疫苗和疗法。
Expert Opin Biol Ther. 2002 Dec;2(8):919-28. doi: 10.1517/14712598.2.8.919.
9
Therapy: An immune one-two punch.治疗方法：免疫的双重打击。
Nature. 2015 Dec 17;528(7582):S134-6. doi: 10.1038/528S134a.
10
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.基于肽的疫苗诱导肿瘤特异性T细胞免疫用于癌症免疫治疗。
Immunotechnology. 1996 Nov;2(4):241-51. doi: 10.1016/s1380-2933(96)00057-7.
引用本文的文献
1
Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications.cGAS-STING 激活、肿瘤免疫逃逸及治疗意义的最新进展
Med Oncol. 2024 Oct 18;41(11):291. doi: 10.1007/s12032-024-02539-7.
2
Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system.恶病质对消化系统恶性肿瘤免疫治疗疗效及预后的影响。
Cancer Rep (Hoboken). 2024 May;7(5):e2100. doi: 10.1002/cnr2.2100.
3
Dynamic intervention to enhance the stability of PEGylated Ibrutinib loaded lipidic nano-vesicular systems: transitioning from colloidal dispersion to lyophilized product.动态干预增强载有 PEG 伊布替尼的脂质纳米囊泡系统的稳定性：从胶体分散体向冻干产品的转变。
Drug Deliv Transl Res. 2024 Nov;14(11):3269-3290. doi: 10.1007/s13346-024-01555-4. Epub 2024 Mar 8.
4
Breast cancer immunotherapy: a comprehensive review.乳腺癌免疫治疗：全面综述。
Clin Exp Med. 2023 Dec;23(8):4431-4447. doi: 10.1007/s10238-023-01177-z. Epub 2023 Sep 1.
5
Type 1 and type 2 cytokine-mediated immune orchestration in the tumour microenvironment and their therapeutic potential.1型和2型细胞因子介导的肿瘤微环境中的免疫调控及其治疗潜力。
Explor Target Antitumor Ther. 2023;4(3):474-497. doi: 10.37349/etat.2023.00146. Epub 2023 Jun 30.
6
A Systematic Analysis of the Role of Unc-5 Netrin Receptor A (UNC5A) in Human Cancers.UNC5A 在人类癌症中的作用的系统分析。
Biomolecules. 2022 Dec 6;12(12):1826. doi: 10.3390/biom12121826.
7
T-Cell Responses to Immunodominant Listeria Epitopes Limit Vaccine-Directed Responses to the Colorectal Cancer Antigen, Guanylyl Cyclase C.T 细胞对免疫显性李斯特菌表位的反应限制了疫苗对结直肠癌抗原、鸟苷酸环化酶 C 的靶向反应。
Front Immunol. 2022 Mar 9;13:855759. doi: 10.3389/fimmu.2022.855759. eCollection 2022.
8
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.HER2阳性乳腺癌的免疫治疗：一项系统综述。
Breast Care (Basel). 2022 Feb;17(1):63-70. doi: 10.1159/000514860. Epub 2021 Mar 29.
9
Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.核酸和寡核苷酸在癌症免疫治疗中激活固有免疫的递送。
J Control Release. 2022 May;345:586-600. doi: 10.1016/j.jconrel.2022.03.045. Epub 2022 Mar 26.
10
Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer.一种基于氧化还原驱动的结直肠癌预后标志物的推导与临床验证
Front Oncol. 2021 Oct 27;11:743703. doi: 10.3389/fonc.2021.743703. eCollection 2021.
本文引用的文献
1
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.系统性 RNA 递送至树突状细胞利用抗病毒防御机制进行癌症免疫治疗。
Nature. 2016 Jun 16;534(7607):396-401. doi: 10.1038/nature18300. Epub 2016 Jun 1.
2
MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.用于结直肠高级腺瘤患者的 MUC1 疫苗：癌症免疫预防可行性研究。
Cancer Prev Res (Phila). 2013 Jan;6(1):18-26. doi: 10.1158/1940-6207.CAPR-12-0275. Epub 2012 Dec 17.
Zotero 插件